REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Parapharm Homeopatijos Vaistine (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: UAB Parapharm Homeopatijos Vaistine Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Parapharm Homeopatijos Vaistine is an enterprise in Lithuania, with the main office in Kaunas. The company operates in the Pharmacies and Drug Stores sector. UAB Parapharm Homeopatijos Vaistine was incorporated on March 27, 2002. 10 (2025) employees currently work for UAB Parapharm Homeopatijos Vaistine. In its most recent financial highlights, the company reported a net sales revenue increase of 18.17% in 2024. UAB Parapharm Homeopatijos Vaistine’s net profit margin increased by 4.24% in 2024.

Headquarters
Vaistines skg. 9-1
Kaunas; Kaunas County;

Contact Details: Purchase the UAB Parapharm Homeopatijos Vaistine report to view the information.

Basic Information
Total Employees:
Purchase the UAB Parapharm Homeopatijos Vaistine report to view the information.
Registered Capital:
Purchase the UAB Parapharm Homeopatijos Vaistine report to view the information.
Financial Auditors:
Purchase the UAB Parapharm Homeopatijos Vaistine report to view the information.
Incorporation Date:
March 27, 2002
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Parapharm Homeopatijos Vaistine report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.17%
Total operating revenue
18.17%
Net Profit (Loss) for the Period
285.29%
Total Equity
39.55%
Net Profit Margin
4.24%
Return on Equity (ROE)
18.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?